Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.10. | Linzer KI-Startup Optimind automatisiert Landingpage-Optimierung mit selbstlernenden System | 1 | der brutkasten | ||
11.09. | Optimind Pharma Corp: Optimind Pharma to remain halted | 1 | Stockwatch | ||
11.09. | CSE Bulletin: Halted for Fundamental Change - Optimind Pharma Corp. (OMND) | 223 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 11 septembre/September 2025) - Trading in the shares of Optimind Pharma Corp. (OMND) will remain halted pending receipt and review of acceptable documentation... ► Artikel lesen | |
08.09. | Optimind Pharma Corp.: Optimind Pharma Announces Definitive Agreement for Proposed Change of Business with InterviewDesk | 371 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 8, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") is pleased to announce that it has entered into a binding definitive share... ► Artikel lesen | |
05.09. | Optimind Pharma Corp: Optimind cancels Monjin acquisition | 1 | Stockwatch | ||
04.09. | Optimind Pharma Corp.: Optimind Pharma Announces Termination of Letter of Intent | 421 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 4, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that its previously announced non-binding letter of intent dated... ► Artikel lesen | |
OPTIMIND PHARMA Aktie jetzt für 0€ handeln | |||||
18.06. | Optimind: KI-Startup holt sechsstellige Förderung für automatisierte Landingpage-Optimierung | 2 | der brutkasten | ||
18.06. | Optimind: AI-Startup für digitales Marketing erhält sechsstellige FFG-Förderung | 3 | Trending Topics | ||
25.03. | Optimind Pharma Corp.: Optimind Pharma Enters into Letter of Intent with Monjin to Acquire AI Business | 672 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 24, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that it has entered into a non-binding letter of intent dated March... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVO NORDISK | 49,720 | +0,42 % | Novo Nordisk: Experten bewerten Wachstumsaussichten | Bei Novo Nordisk gehen die Einschätzungen der Analysten auseinander. Während einige Research-Häuser auf Risiken durch abnehmende Verschreibungstrends verweisen, sehen andere Institute kurzfristig Chancen... ► Artikel lesen | |
AURORA CANNABIS | 4,850 | +6,36 % | Piramal Pharma Solutions Implements POD Method at Aurora API Facility | ||
CANOPY GROWTH | 1,278 | +7,94 % | Canopy Growth Corp (2): Canopy's DOJA facility now a medical cultivation site | ||
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
BIOTEST | 28,200 | -4,73 % | EQS-News: Biotest AG: Biotest's Yimmugo® launches in the United States | EQS-News: Biotest AG
/ Key word(s): Product Launch
Biotest's Yimmugo® launches in the United States
09.10.2025 / 17:30 CET/CEST
The issuer is solely responsible for... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
SINOPHARM | 2,020 | -0,30 % | SINOPHARM (01099): NOTICE OF BOARD MEETING | ||
INDIVA | 0,016 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.06.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.06.2025.ISIN NameCA45580J1012 INDIVA... ► Artikel lesen | |
ASTRIA THERAPEUTICS | 7,300 | +2,10 % | Astria Therapeutics, Inc.: Astria Therapeutics rekrutiert nun HAE-Patienten in der Europäischen Union für die Phase-3-Studie ALPHA-ORBIT | Astria Therapeutics, Inc. (Nasdaq:ATXS), ein Biopharma-Unternehmen mit Schwerpunkt auf der Entwicklung lebensverändernder Therapien für allergische und immunologische Erkrankungen, gab heute bekannt... ► Artikel lesen | |
CSPC PHARMA | 1,063 | +4,52 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - SYH2070 INJECTION (A DOUBLE-STRANDED SMALL INTERFERING RNA DRUG) OBTAINS CLINICAL TRIAL APPROVAL IN THE ... | ||
TONIX PHARMACEUTICALS | 17,500 | -4,37 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025 | ||
ORAMED PHARMACEUTICALS | 2,062 | -0,87 % | ORAMED PHARMACEUTICALS INC. - 8-K, Current Report | ||
ADASTRA | 0,101 | -17,21 % | Adastra Holdings Ltd.: Adastra Holdings Enters into Agreements to Sell Subsidiaries | Langley, British Columbia--(Newsfile Corp. - October 8, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has entered into agreements to sell all of the issued... ► Artikel lesen | |
AXSOME THERAPEUTICS | 106,90 | +1,96 % | Axsome Therapeutics, Inc.: Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community |